This National Cancer Institute (NCI) grant supports the development and validation of user-friendly, low-cost technologies for cancer prevention, detection, diagnosis, and treatment in low- and middle-income countries (LMICs). The grant seeks applications to adapt existing device or assay prototypes for cancer applications in these global settings. Projects must demonstrate technical functionality and clinical performance, meeting objective milestones in LMICs. Multidisciplinary teams, including expertise in engineering, oncology, global healthcare, and business development, are required. Design must prioritize affordability, cost-effectiveness, and point-of-need usability. This initiative is part of NCI’s Affordable Cancer Technologies Program.
Opportunity ID: 347657
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-24-005 |
| Funding Opportunity Title: | Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 20, 2023 |
| Last Updated Date: | Apr 20, 2023 |
| Original Closing Date for Applications: | Oct 13, 2023 |
| Current Closing Date for Applications: | Oct 13, 2023 |
| Archive Date: | Nov 18, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $475,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts State governments Special district governments Public housing authorities/Indian housing authorities City or township governments County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Private institutions of higher education Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting, diagnosing, and/or treating cancers in people living in LMICs.Applicants should have a working assay or device prototype (not necessarily already capable of cancer applications). The U01 project includes studies to both adapt this technology as well as demonstrate technical functionality and clinical performance for use of the device or assay in specific LMIC settings by meeting objective performance milestones followed by improvements and validations of the technologies in the LMIC settings. Projects proposed in response to this FOA will require multidisciplinary efforts to succeed; therefore, all applicant teams must include expertise in engineering/assay/treatment development, oncology, global healthcare delivery, and business development. Investigators responding to this FOA must consider affordability and cost-effectiveness as well as usability at the point-of-need as part of their design criteria.This funding opportunity is part of a broader NCI-sponsored Affordable Cancer Technologies (ACTs) Program. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-24-005.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 347657 Full Announcement-RFA-CA-24-005 -> RFA-CA-24-005-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00281275 | Sep 13, 2023 | Oct 13, 2023 | View |
Package 1
Mandatory forms
347657 RR_SF424_5_0-5.0.pdf
347657 PHS398_CoverPageSupplement_5_0-5.0.pdf
347657 RR_OtherProjectInfo_1_4-1.4.pdf
347657 PerformanceSite_4_0-4.0.pdf
347657 RR_KeyPersonExpanded_4_0-4.0.pdf
347657 PHS398_ResearchPlan_5_0-5.0.pdf
347657 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
347657 RR_Budget_3_0-3.0.pdf
347657 RR_SubawardBudget30_3_0-3.0.pdf
347657 PHS398_ModularBudget_1_2-1.2.pdf
347657 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
